Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...
Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...